BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1194 related articles for article (PubMed ID: 19374581)

  • 1. Staphylococcus aureus bloodstream infections: definitions and treatment.
    Corey GR
    Clin Infect Dis; 2009 May; 48 Suppl 4():S254-9. PubMed ID: 19374581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staphylococcus aureus bacteremia: epidemiology, pathophysiology, and management strategies.
    Naber CK
    Clin Infect Dis; 2009 May; 48 Suppl 4():S231-7. PubMed ID: 19374578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients at risk of complications of Staphylococcus aureus bloodstream infection.
    del Rio A; Cervera C; Moreno A; Moreillon P; Miró JM
    Clin Infect Dis; 2009 May; 48 Suppl 4():S246-53. PubMed ID: 19374580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Future strategies for treating Staphylococcus aureus bloodstream infections.
    Naber CK
    Clin Microbiol Infect; 2008 Mar; 14 Suppl 2():26-34. PubMed ID: 18226087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and management of Staphylococcus aureus bacteraemia.
    Mitchell DH; Howden BP
    Intern Med J; 2005 Dec; 35 Suppl 2():S17-24. PubMed ID: 16271058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
    Sakoulas G; Moellering RC
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S360-7. PubMed ID: 18462091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of vancomycin in the treatment paradigm.
    Stevens DL
    Clin Infect Dis; 2006 Jan; 42 Suppl 1():S51-7. PubMed ID: 16323121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal bacteraemia and infective endocarditis due to meticillin-resistant Staphylococcus aureus (MRSA) with rapid emergence of rifampicin resistance during vancomycin/rifampicin combination treatment.
    Liu WL; Hung YL; Lin SH; Lee PI; Hsueh PR
    Int J Antimicrob Agents; 2010 Jun; 35(6):615-6. PubMed ID: 20236804
    [No Abstract]   [Full Text] [Related]  

  • 9. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006.
    Laupland KB; Ross T; Gregson DB
    J Infect Dis; 2008 Aug; 198(3):336-43. PubMed ID: 18522502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of methicillin-resistant Staphylococcus aureus bacteremia.
    Cosgrove SE; Fowler VG
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S386-93. PubMed ID: 18462094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia: a retrospective cohort study.
    Goldberg E; Paul M; Talker O; Samra Z; Raskin M; Hazzan R; Leibovici L; Bishara J
    J Antimicrob Chemother; 2010 Aug; 65(8):1779-83. PubMed ID: 20507860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem.
    Jang HC; Kim SH; Kim KH; Kim CJ; Lee S; Song KH; Jeon JH; Park WB; Kim HB; Park SW; Kim NJ; Kim EC; Oh MD; Choe KW
    Clin Infect Dis; 2009 Aug; 49(3):395-401. PubMed ID: 19569970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan.
    Huang YT; Hsiao CH; Liao CH; Lee CW; Hsueh PR
    J Clin Microbiol; 2008 Mar; 46(3):1132-6. PubMed ID: 18199793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Empirical therapy for serious Gram-positive infections: making the right choice.
    Segreti J
    Clin Microbiol Infect; 2009 Dec; 15 Suppl 6():5-10. PubMed ID: 19917021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of increase in time to blood culture positivity in a patient with persistent methicillin-resistant Staphylococcus aureus bacteremia predicts failure of antimicrobial therapy.
    Liao CH; Huang YT; Chu FY; Lin TH; Hsueh PR
    J Microbiol Immunol Infect; 2008 Aug; 41(4):355-7. PubMed ID: 18787745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staphylococcus aureus bacteremia and endocarditis.
    Chang FY
    J Microbiol Immunol Infect; 2000 Jun; 33(2):63-8. PubMed ID: 10917874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Audit of the management of Staphylococcus aureus bloodstream infection: gaps to be plugged.
    Barry A; McNicholas S; Smyth E; Humphreys H; Fitzpatrick F
    J Hosp Infect; 2010 Nov; 76(3):272-3. PubMed ID: 20435374
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.
    Soriano A; Marco F; Martínez JA; Pisos E; Almela M; Dimova VP; Alamo D; Ortega M; Lopez J; Mensa J
    Clin Infect Dis; 2008 Jan; 46(2):193-200. PubMed ID: 18171250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methicillin-resistant Staphylococcus aureus infection with intermediate sensitivity to vancomycin: a case report and literature review.
    Schairer J; Sankri-Tarbichi AG; Fairfax MR; Salimnia H; Guzman JA
    J Intensive Care Med; 2008; 23(5):338-41. PubMed ID: 18701528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Consensus document for the treatment of bacteremia and endocarditis caused by methicillin-resistent Staphylococcus aureus. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica].
    Gudiol F; Aguado JM; Pascual A; Pujol M; Almirante B; Miró JM; Cercenado E; Domínguez Mde L; Soriano A; Rodríguez-Baño J; Vallés J; Palomar M; Tornos P; Bouza E;
    Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):105-15. PubMed ID: 19254641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.